Allergan Korea seeks sole marketing of Botox

Allergan Korea says it would stop the joint marketing of an antiwrinkle therapy Botox with Daewoong Pharm to conduct its sole marketing from next January.

Daewoong honored Allergan’s sole marketing in consideration of the longstanding relationship between two companies and plans to seek a closer collaboration in the mutually profitable business.

The insurance coverage of Botox has been ex...